Office of Medical Cannabis Seeks Comment on Proposed New Qualifying Conditions
September 1, 2022
The Office of Medical Cannabis is accepting public written comment on petitions to add qualifying medical conditions for Minnesota’s Medical Cannabis Program. The deadline is the end of business on October 5.
The petitions under consideration are gastroparesis, irritable bowel syndrome, obsessive compulsive disorder and opioid use disorder.
The Minnesota Department of Health (MDH) accepts petitions from the public every year from June 1 through July 31 to add a qualifying medical condition or delivery method. No petitions for adding new delivery methods were accepted for consideration.
You can submit comments via email or by US mail: Office of Medical Cannabis, PO Box 64882, St. Paul, MN 55164.
This fall, MDH will send all eligible petitions, scientific reviews developed by MDH staff, and public written comments to the Medical Cannabis Review Panel, which will meet to review the materials. The date for the review panel meeting is to be determined.
By November 1, the panel will provide the health commissioner with a written report of the findings, identifying potential public health benefits and potential risks by adding or not adding a proposed condition. The commissioner will approve or deny petitions by December 1.
To learn more, visit Petitions Process for Adding Qualifying Medical Conditions, Delivery Methods.
News
Office of Medical Cannabis Seeks Comment on Proposed New Qualifying Conditions
September 1, 2022
The Office of Medical Cannabis is accepting public written comment on petitions to add qualifying medical conditions for Minnesota’s Medical Cannabis Program. The deadline is the end of business on October 5.
The petitions under consideration are gastroparesis, irritable bowel syndrome, obsessive compulsive disorder and opioid use disorder.
The Minnesota Department of Health (MDH) accepts petitions from the public every year from June 1 through July 31 to add a qualifying medical condition or delivery method. No petitions for adding new delivery methods were accepted for consideration.
You can submit comments via email or by US mail: Office of Medical Cannabis, PO Box 64882, St. Paul, MN 55164.
This fall, MDH will send all eligible petitions, scientific reviews developed by MDH staff, and public written comments to the Medical Cannabis Review Panel, which will meet to review the materials. The date for the review panel meeting is to be determined.
By November 1, the panel will provide the health commissioner with a written report of the findings, identifying potential public health benefits and potential risks by adding or not adding a proposed condition. The commissioner will approve or deny petitions by December 1.
To learn more, visit Petitions Process for Adding Qualifying Medical Conditions, Delivery Methods.
More Publications
Latest News
Prior Authorization Exemption for Buprenorphine Heard in Senate Committee
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
Legislation to Expand Collaborative Care Model Heard in Senate HHS Committee
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
House Committee Hears Legislation to Support Hennepin Healthcare System
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.